BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bumanlag IM, Jaoude JA, Rooney MK, et al. (2022) Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations. Seminars in Radiation Oncology. 32: 125-134 |
| Patel RR, Parisi R, Verma V, et al. (2022) Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers. 14 |
| Abi Jaoude J, Thunshelle CP, Kouzy R, et al. (2021) Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Advances in Radiation Oncology. 6: 100763 |
| Corrigan KL, Kry S, Howell RM, et al. (2021) The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology |
| Abi Jaoude J, Kouzy R, Rooney M, et al. (2021) Impact factor and citation metrics in phase III cancer trials. Oncotarget. 12: 1780-1786 |
| Fokas E, Appelt A, Glynne-Jones R, et al. (2021) International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nature Reviews. Clinical Oncology |
| Metzger AL, Kusi Appiah A, Wright CM, et al. (2021) Financial Relationships Between Industry and Principal Investigators of United States Cooperative Group Randomized Cancer Clinical Trials. International Journal of Cancer |
| Abi Jaoude J, Kouzy R, Ghabach M, et al. (2021) Food and Drug Administration approvals in phase 3 Cancer clinical trials. Bmc Cancer. 21: 695 |
| Pasalic D, Fuller CD, Mainwaring W, et al. (2021) Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials. Mayo Clinic Proceedings. 96: 420-426 |
| De B, Kaiser KW, Ludmir EB, et al. (2020) Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncologica (Stockholm, Sweden). 1-4 |